Side effects can enhance treatment response through expectancy effects: An experimental analgesic randomized controlled trial

Pain

Volumn 158, Issue 6, 2017, Pages 1014-1020

  Berna, Chantal ^a,b,c   Kirsch, Irving ^b   Zion, Sean R ^c   Lee, Yvonne C ^c   Jensen, Karin B ^b,d   Sadler, Pamela ^e   Kaptchuk, Ted J ^b   Edwards, Robert R ^c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e WILFRID LAURIER UNIVERSITY   (Canada)

Author keywords

Expectancy; Induced side effects; NSAID; Placebo analgesia; RCT model; Unblinding

Indexed keywords

ATROPINE; DICLOFENAC; PLACEBO; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANALGESIA; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG POTENTIATION; DRUG RESPONSE; FEMALE; HEALTH BELIEF; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PLACEBO EFFECT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; XEROSTOMIA; ADOLESCENT; ANTICIPATION; CHEMICALLY INDUCED; DRUG EFFECTS; PAIN; PAIN MEASUREMENT; PSYCHOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICIPATION, PSYCHOLOGICAL; ATROPINE; DICLOFENAC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PAIN; PAIN MEASUREMENT; PLACEBO EFFECT; TREATMENT OUTCOME; XEROSTOMIA; YOUNG ADULT;

EID: 85019946833     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1097/j.pain.0000000000000870     Document Type: Article

References (65)

1. Amanzio M, Pollo A, Maggi G, Benedetti F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. PAIN 2001;90:205-15.
2. Aslaksen PM, Zwarg ML, Eilertsen HI, Gorecka MM, Bjorkedal E. Opposite effects of the same drug: reversal of topical analgesia by nocebo information. PAIN 2015;156:39-46.
3. Atlas LY, Bolger N, Lindquist MA, Wager TD. Brain mediators of predictive cue effects on perceived pain. J Neurosci 2010;30:12964-77.
4. Atlas LY, Whittington RA, Lindquist MA, Wielgosz J, Sonty N, Wager TD. Dissociable influences of opiates and expectations on pain. J Neurosci 2012;32:8053-64.
5. Atlas LY, Wielgosz J, Whittington RA, Wager TD. Specifying the nonspecific factors underlying opioid analgesia: expectancy, attention, and affect. Psychopharmacology (Berl) 2014;231:813-23.
6. Averbuch M, Katzper M. A search for sex differences in response to analgesia. Arch Intern Med 2000;160:3424-8.
7. Baethge C, Assall OP, Baldessarini RJ. Systematic review of blinding assessment in randomized controlled trials in schizophrenia and affective disorders 2000-2010. Psychother Psychosom 2013;82:152-60.
8. Bausell RB, Lao L, Bergman S, Lee WL, Berman BM. Is acupuncture analgesia an expectancy effect? Preliminary evidence based on participants' perceived assignments in two placebo-controlled trials. Eval Health Prof 2005;28:9-26.
9. Beck AT, Steer RA, Brown GK. Manual for the beck depression inventory-II. San Antonio: Psychological Corporation, 1996.
10. Benedetti F, Carlino E, Piedimonte A. Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects. Lancet Neurol 2016;15:736-47.
11. Bingel U, Wanigasekera V, Wiech K, Ni Mhuircheartaigh R, Lee MC, Ploner M, Tracey I. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med 2011;3:70ra14.
12. Bubic A, Von Cramon DY, Schubotz R. Prediction, cognition and the brain. Front Hum Neurosci 2010;4:25.
13. Butcher BE, Carmody JJ. Sex differences in analgesic response to ibuprofen are influenced by expectancy: a randomized, crossover, balanced placebo-designed study. Eur J Pain 2012;16:1005-13.
14. Cardenas DD, Warms CA, Turner JA, Marshall H, Brooke MM, Loeser JD. Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial. PAIN 2002;96:365-73.
15. Chen JA, Papakostas GI, Youn SJ, Baer L, Clain AJ, Fava M, Mischoulon D. Association between patient beliefs regarding assigned treatment and clinical response: reanalysis of data from the Hypericum Depression Trial Study Group. J Clin Psychiatry 2011;72:1669-76.
16. Clark A. Embodied prediction. In: Metzinger TK, Windt JM, editors. Open MIND. Frankfurt am Main: MIND Group, 2015.
17. Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt versus covert treatment for pain, anxiety, and Parkinson's disease. LancetNeurol 2004; 3:679-84.
18. Compton P, Charuvastra VC, Ling W. Effect of oral ketorolac and gender on human cold pressor pain tolerance. Clin Exp Pharmacol Physiol 2003; 30:759-63.
19. Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J, Buchel C. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 2009;63:533-43.
20. Enck P, Klosterhalfen S, Weimer K, Horing B, Zipfel S. The placebo response in clinical trials: more questions than answers. Philos Trans R Soc Lond B Biol Sci 2011;366:1889-95.
21. Frazier PA, Tix AP, Barron KE. Testing moderator and mediator effects in counseling psychology research. J Couns Psychol 2004;51:115.
22. Fry JR, Burr SA. A double-blind atropine trial for active learning of autonomic function. Adv Physiol Educ 2011;35:438-44.
23. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377-81.
24. Jensen KB, Kaptchuk TJ, Chen X, Kirsch I, Ingvar M, Gollub RL, Kong J. A neural mechanism for nonconscious activation of conditioned placebo and nocebo responses. Cereb Cortex 2015;25:3903-10.
25. Jensen KB, Kaptchuk TJ, Kirsch I, Raicek J, Lindstrom KM, Berna C, Gollub RL, Ingvar M, Kong J. Nonconscious activation of placebo and nocebo pain responses. Proc Natl Acad Sci USA 2012;109:15959-64.
26. Jensen MP, Karoly P, Braver S. The measurement of clinical pain intensity: a comparison of six methods. PAIN 1986;27:117-26.
27. Kenny DA, Judd CM. Power anomalies in testing mediation. Psychol Sci 2014;25:334-9.
28. Kirsch I, Rosadino MJ. Do double-blind studies with informed consent yield externally valid results? An empirical test. Psychopharmacology (Berl) 1993;110:437-42.
29. Krumova EK, Zeller M, Westermann A, Maier C. Lidocaine patch (5%) produces a selective, but incomplete block of Adelta and C fibers. PAIN 2012;153:273-80.
30. Kube T, Rief W. Are placebo and drug-specific effects additive? Questioning basic assumptions of double-blinded randomized clinical trials and presenting novel study designs. Drug Discov Today 2017. doi: 10.1016/j.drudis.2016.11.022. [Epub ahead of print].
31. Levine J, Gordon N, Fields H. The mechanism of placebo analgesia. Lancet 1978;312:654-7.
32. Loggia ML, Jensen K, Gollub RL, Wasan AD, Edwards RR, Kong J. The catechol-O-methyltransferase (COMT) val158met polymorphism affects brain responses to repeated painful stimuli. PLoS One 2011;6:e27764.
33. Lund K, Vase L, Petersen GL, Jensen TS, Finnerup NB. Randomised controlled trials may underestimate drug effects: balanced placebo trial design. PLoS One 2014;9:e84104.
34. Margraf J, Ehlers A, Roth WT, Clark DB, Sheikh J, Agras WS, Taylor CB. How "blind" are double-blind studies? J Consult Clin Psychol 1991;59: 184-7.
35. Marret E, Kurdi O, Zufferey P, Bonnet F. Effects of nonsteroidal antiinflammatory drugs on patient-controlled analgesia morphine side effects: meta-analysis of randomized controlled trials. Anesthesiology 2005;102:1249-60.
36. Max MB, Schafer SC, Culnane M, Dubner R, Gracely RH. Association of pain relief with drug side effects in postherpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen, and placebo. Clin Pharmacol Ther 1988;43:363-71.
37. Miranda HF, Pinardi G. Lack of effect of naltrindole on the spinal synergism of morphine and non-steroidal anti-inflammatory drugs (NSAIDS). J Physiol Pharmacol 2009;60:71-6.
38. Miranda HF, Prieto JC, Pinardi G. Spinal synergy between nonselective cyclooxygenase inhibitors and morphine antinociception in mice. Brain Res 2005;1049:165-70.
39. Moore RA, Derry S, McQuay HJ, Wiffen PJ. Single dose oral analgesics for acute postoperative pain in adults. Cochrane Database Syst Rev 2011;Cd008659.
40. Papakostas GI, Fava M. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD. Eur Neuropsychopharmacol 2009;19: 34-40.
41. Reiss S, Peterson RA, Gursky DM, McNally RJ. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther 1986;24: 1-8.
42. RiefW, Barsky AJ, Glombiewski JA, Nestoriuc Y, Glaesmer H, Braehler E. Assessing general side effects in clinical trials: reference data from the general population. Pharmacoepidemiol Drug Saf 2011;20:405-15.
43. Rief W, Bingel U, Schedlowski M, Enck P. Mechanisms involved in placebo and nocebo responses and implications for drug trials. Clin Pharmacol Ther 2011;90:722-6.
44. Rief W, Glombiewski JA. The hidden effects of blinded, placebocontrolled randomized trials: an experimental investigation. PAIN 2012; 153:2473-7.
45. Rief W, Nestoriuc Y, Weiss S, Welzel E, Barsky AJ, Hofmann SG. Metaanalysis of the placebo response in antidepressant trials. J Affect Disord 2009;118:1-8.
46. Roelofs PD, Deyo RA, Koes BW, Scholten RJ, van Tulder MW. Nonsteroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev 2008;CD000396.
47. Rosen A, Yi J, Kirsch I, Kaptchuk TJ, Ingvar M, Jensen KB. Effects of subtle cognitive manipulations on placebo analgesia-an implicit priming study. Eur J Pain 2016. doi: 10.1002/ejp.961. [Epub ahead of print].
48. Rutherford BR, Roose SP. A model of placebo response in antidepressant clinical trials. Am J Psychiatry 2013;170:723-33.
49. Rutherford BR, Sneed JR, Roose SP. Does study design influence outcome? The effects of placebo control and treatment duration in antidepressant trials. Psychother Psychosom 2009;78:172-81.
50. Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the life orientation test. J Pers Soc Psychol 1994;67:1063-78.
51. Schenk LA, Sprenger C, Geuter S, Buchel C. Expectation requires treatment to boost pain relief: an fMRI study. PAIN 2014;155:150-7.
52. Shah E, Triantafyllou K, Hana AA, Pimentel M. Adverse events appear to unblind clinical trials in irritable bowel syndrome. Neurogastroenterol Motil 2014;26:482-8.
53. SinyorM, Levitt AJ, Cheung AH, Schaffer A, Kiss A, Dowlati Y, Lanctot KL. Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses. J Clin Psychiatry 2010;71:270-9.
54. Sneed JR, Rutherford BR, Rindskopf D, Lane DT, Sackeim HA, Roose SP. Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. Am J Geriatr Psychiatry 2008;16:65-73.
55. Stacher G, Steinringer H, Schneider S, Mittelbach G, Winklehner S, Gaupmann G. Experimental pain induced by electrical and thermal stimulation of the skin in healthy man: sensitivity to 75 and 150 mg diclofenac sodium in comparison with 60 mg codeine and placebo. Br J Clin Pharmacol 1986;21:35-43.
56. Torres-Lopez JE, Carmona-Diaz E, Cortes-Penaloza JL, Guzman-Priego CG, Rocha-Gonzalez HI. Antinociceptive synergy between diclofenac and morphine after local injection into the inflamed site. Pharmacol Rep 2013;65:358-67.
57. Turner JA, Jensen MP, Warms CA, Cardenas DD. Blinding effectiveness and association of pretreatment expectations with pain improvement in a double-blind randomized controlled trial. PAIN 2002;99:91-9.
58. Tuttle AH, Tohyama S, Ramsay T, Kimmelman J, Schweinhardt P, Bennett GJ, Mogil JS. Increasing placebo responses over time in U.S. clinical trials of neuropathic pain. PAIN 2015;156:2616-26.
59. Vase L, Amanzio M, Price DD. Nocebo vs. Placebo: the challenges of trial design in analgesia research. Clin Pharmacol Ther 2015;97:143-50.
60. Vase L, Baram S, Takakura N, Yajima H, Takayama M, Kaptchuk TJ, Schou S, Jensen TS, Zachariae R, Svensson P. Specifying the nonspecific components of acupuncture analgesia. PAIN 2013;154: 1659-67.
61. Waber RL, Shiv B, Carmon Z, Ariely D. Commercial features of placebo and therapeutic efficacy. JAMA 2008;299:1016-17.
62. Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression: variable, substantial, and growing. JAMA 2002;287: 1840-7.
63. Weimer K, Colloca L, Enck P. Placebo effects in psychiatry: mediators and moderators. Lancet Psychiatry 2015;2:246-57.
64. Weimer K, Enck P. Traditional and innovative experimental and clinical trial designs and their advantages and pitfalls. Handb Exp Pharmacol 2014;225:237-72.
65. Wise RA, Bartlett SJ, Brown ED, Castro M, Cohen R, Holbrook JT, Irvin CG, Rand CS, Sockrider MM, Sugar EA; American Lung Association Asthma Clinical Research Centers. Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers. J Allergy Clin Immunol 2009;124:436-44, 444e431-438.